Stock data
Beam Therapeutics Inc. (BEAM)
Beam Therapeutics Inc. (BEAM) reported revenue of US$139.74M and net income of -US$79.99M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$139.74M | — | -US$383.69M | -US$79.99M | — |
| 2024 | US$63.52M | — | -US$415.57M | -US$376.74M | — |
| 2023 | US$377.71M | — | -US$176.49M | -US$132.53M | — |
| 2022 | US$60.92M | — | -US$338.48M | -US$289.09M | — |
| 2021 | US$51.84M | — | -US$392.46M | -US$370.64M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$0.49M | -US$122.68M | — |
| 2026-03-31 | US$31.74M | -US$94.32M | — |
| 2025-12-31 | US$114.11M | US$243.20M | — |
| 2025-09-30 | US$9.70M | -US$112.73M | — |
| 2025-06-30 | US$8.47M | -US$102.14M | — |
| 2025-03-31 | US$7.47M | -US$108.33M | — |
| 2024-12-31 | US$30.07M | -US$90.35M | — |
| 2024-09-30 | US$14.27M | -US$96.67M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.